The invention discloses a new kind of RNA binding protein 33 and polynucleotide
encoding the polypeptide and a process for producing the polypeptide by recombinant
methods. It also discloses the method of applying the polypeptide for the treatment
of various kinds of diseases, such as cancer, hemopathology, HIV infection, immune
diseases and inflammation. The antibody and antagonist of the polypeptide and the
therapeutic use of the same is also disclosed. In addition, it refers to the use
of polynucleotide encoding said RNA binding protein 33.
